Predictors of 5-year survival in patients with chronic heart failure and reduced left ventricular ejection fraction depending on the presence of type 2 diabetes mellitus

2021 ◽  
Vol 28 (4) ◽  
pp. 33-39
Author(s):  
L. G. Voronkov ◽  
N. A. Tkach ◽  
O. L. Filatova ◽  
T. I. Gavrilenko

The aim – to determine the predictors of 5-year survival of patients with CHF and reduced LV EF depending on the presence of type 2 diabetes mellitus.Materials and methods. 490 case histories of patients in the period from 2011 to 2018 with CHF, 40–80 years of age (median – 64 years), II–IV NYHA functional class, LVEF ≤ 40 % were analyzed. For the analysis of all patients with CHF and reduced LV EF were divided into two groups: Group I included 338 (69 %) patients without diabetes mellitus type 2, group II consisted of 152 (31 %) patients diagnosed with diabetes mellitus type 2. To measure the values ​​of the independent predictors, we calculated the value of the odds ratio (OR) with a 95 % confidence interval. To determine predictors of mortality/survival of the studied patients, was calculated the Хі-square criterion. Additionally, we calculated the estimate of the frequency difference between the groups, the odds ratio, the confidence interval for the odds ratio, the Pearson correlation coefficient r, for all the calculated characteristics we determined the probability of error of the first kind p. As a result, we formed a final table of indicators-predictors of mortality/survival of patients with CHF with reduced LV EF with and without diabetes mellitus type 2 for which there is a statistical relationship between mortality / survival and the studied indicator.Results and discussion. In patients without diabetes, many indicators are associated with the prognosis of long-term survival. These include hemodynamic parameters (heart rate, the left atrium size (LV) and indexed left ventricular (LV) volumes, LV myocardial mass index, right ventricular size (RV) and LV ejection fraction, renal function parameters (microalbuminuria (UIA), glomerular filtration rate (GFR), urea nitrogen), systemic inflammatory marker (C-reactive protein (CRP)), markers of systemic oxidative stress (myeloperoxidase, citrulline, uric acid) and antioxidant defence – SOD, as well as the N-terminal fragment of the precursor of natriuretic peptide (NT-proBNP), flow-dependent vasodilatory response (FDVR), high-density lipoprotein cholesterol (HDL), insulin and the relative content of lymphocytes in the blood. Patients with diabetes had significantly fewer such predictors: in addition to parameters of intracardiac hemodynamics and heart modeling, other significant predictors of 5-year survival were daily UIA level, CRP, SOD, HDL, insulin and the lymphocyte level.Conclusions. Quantitative predictors of poor 5-year survival prognosis among patients with CHF and reduced LV EF with and without concomitant diabetes mellitus type 2 are parameters of heart remodeling, LV systolic function-EF, UIA level, antioxidant stress marker (SOD), HDL level, blood lymphocytes and the level of circulating insulin. Patients without diabetes are characterized by a wider range of poor long-term survival predictors, which include indicators of renal nitrogen function, markers of systemic oxidative stress (myeloperoxidase, citrulline, uric acid), flow-dependent vasodilatory response and circulating NT-proBNP. The determined quantitative predictors can be used in algorithms of individual prediction of the course of CHF and reduced LV EF, which should be created separately for patients with and without concomitant diabetes mellitus type 2

2014 ◽  
Vol 17 (2) ◽  
pp. 266-274 ◽  
Author(s):  
Majken Linnemann Jensen ◽  
Marit Eika Jørgensen ◽  
Ebba Holme Hansen ◽  
Lise Aagaard ◽  
Bendix Carstensen

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii545-iii545
Author(s):  
Elena Jordanova ◽  
Sanja Simic Ogrizovic ◽  
Vladimir Samardzic ◽  
Violeta Dopsaj ◽  
Ljiljana Bokan ◽  
...  

Author(s):  
А. І Балабан ◽  
Н. І Ярема ◽  
О. І Коцюба

ЗМІНИ ДІАСТОЛІЧНОЇ ФУНКЦІЇ ЛІВОГО ШЛУНОЧКА ТА КИСНЕВОГО ЗАБЕЗПЕЧЕННЯ НИЖНІХ КІНЦІВОК ПРИ КОМОРБІДНИХ СТАНАХ - Представлено результати особливостей змін діастолічної функції лівого шлуночка і показників оксигенації артеріальної та венозної крові у хворих на ІХС: стабільну стенокардію напруження із супутнім цукровим діабетом 2 типу. Відмічено виражену діастолічну дисфункцію лівого шлуночка та зниження показників оксигенації артеріальної та венозної крові при наявності супутнього цукрового діабету 2 типу.<br />ИЗМЕНЕНИЯ ДИАСТОЛИЧЕСКОЙ ФУНКЦИИ ЛЕВОГО ЖЕЛУДОЧКА И КИСЛОРОДНОГО ОБЕСПЕЧЕНИЯ НИЖНИХ КОНЕЧНОСТЕЙ ПРИ КОМОРБИДНЫХ СОСТОЯНИЯХ -Представлены результаты особенностей изменений диастолической функции левого желудочка и показателей оксигенации артериальной и венозной крови у больных ИБС: стабильную стенокардию напряжения с сопутствующим сахарным диабетом 2 типа. Отмечено выраженную диастолическую дисфункцию левого желудочка и снижение показателей оксигенации артериальной и венозной крови при наличии сопутствующего сахарного диабета 2 типа.<br />VIOLATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION AND OXYGEN SUPPLY OF THE LOWER EXTREMITIES AT COMORBID CONDITIONS - The results of the peculiarities of changes of diastolic left ventricular function and oxygenation indices of arterial and venous blood in patients with coronary heart disease: stable angina pectoris with concomitant diabetes mellitus type 2 was shown. Marked a pronounced left ventricular diastolic dysfunction and decrease oxygenation of arterial and venous blood in the presence of concomitant diabetes mellitus type 2.<br />Ключові слова: діастолічна дисфункція лівого шлуночка, стенокардія напруження, цукровий діабет 2 типу, сатурація артеріальної та венозної крові, натрійуретич- ний пептид.<br />Ключевые слова: диастолическая дисфункция левого желудочка, стенокардия напряжения, сахарный диабет 2 типа, сатурация артериальной и венозной крови, натрийуретический пептид.<br />Key words: left ventricular diastolic function, angina pectoris, diabetes mellitus type 2, saturation of arterial and venous blood, natriuretic peptide.


2019 ◽  
Vol 18 (27) ◽  
pp. 2327-2337
Author(s):  
Catalina Figueroa-Benavides ◽  
Maria João Matos ◽  
Montserrat Peñaloza-Amion ◽  
Rubén Veas ◽  
Gabriela Valenzuela-Barra ◽  
...  

Diabetes mellitus type 2 (DMT2) is a metabolic disease characterized by a chronic increase in glycemia that promotes several long-term complications and high mortality. Some enzymes involved in glycaemic control, such as α -(1,4)-glucosidase, have now been established as novel pharmacological targets. Coumarins have shown benefits in attenuating signs and complications of DMT2, including inhibition of this enzyme. In this work, new synthetic coumarins (bearing different amide and aryl substituents) were studied in vitro as inhibitors of α-(1,4)-glucosidase. Among them, five molecules proved to be excellent α-(1,4)-glucosidase inhibitors, being compound 7 (IC50 = 2.19 µM) about 200 times more potent than acarbose, a drug currently used for the treatment of DMT2. In addition, most of the coumarins presented uncompetitive inhibition for the α-(1,4)-glucosidase. Molecular docking studies revealed that coumarins bind to the active site of the enzyme in a more external area comparing to the substrate, without interfering with it, and displaying aromatic and hydrophobic interactions, as well as some hydrogen bonds. According to the results, aromatic interactions with two phenylalanine residues, 157 and 177, were the most common among the studied coumarins. This study is a step forward for the understanding of coumarins as potential anti-diabetic compounds displaying α-(1,4)-glucosidase inhibition.


Sign in / Sign up

Export Citation Format

Share Document